Corpus Intelligence IC Memo — AVERA GREGORY HOSPITAL 2026-04-26 04:03 UTC
IC Memo — AVERA GREGORY HOSPITAL
Investment Committee Memorandum | SD | 13 beds | Grade D | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA GREGORY HOSPITAL

CCN 431338 | GREGORY, SD | 13 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

AVERA GREGORY HOSPITAL is a 13-bed rural/critical access in GREGORY, SD with $17.5M in net patient revenue and a -23.5% operating margin. The hospital serves a payer mix of 76.8% Medicare, 5.2% Medicaid, and 18.1% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.5% to -16.1% (+736bps).

Net Revenue HCRIS$17.5M
Current EBITDA COMPUTED$-4.1M
Operating Margin COMPUTED-23.5%
Occupancy HCRIS31.9%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS50.0%
Distress Probability ML56.4%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
37
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -23.5% places it below the state median. Among 37 size-comparable peers (6-26 beds), the median margin is -1.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-26), prioritizing same-state peers. 37 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA GREGORY HOSPITAL (Target)SD13$17.5M-23.5%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
BLACK HILLS SURGICAL HOSPITAL SD26$91.1M15.3%
HURON REGIONAL MEDICAL CENTERSD25$49.4M-5.9%
MONUMENT HEALTH STURGIS REGIONSD25$39.1M-3.3%
MADISON REGIONAL HEALTH SYSTEMSD22$33.8M-1.6%
SANFORD MEDICAL CENTER VERMILLSD25$32.0M8.3%
FALL RIVER HOSPITALSD25$28.4M0.3%
MONUMENT HEALTH CUSTER HOSPITASD12$27.8M-7.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$367K+210bp18mo
Cost to Collect4.5%2.5%$349K+200bp12mo
Denial Rate Reduction12.0%6.5%$346K+198bp12mo
A/R Days Reduction5200.0%3800.0%$213K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$367K
Cost to Collect
$349K
Denial Rate Reduction
$346K
A/R Days Reduction
$213K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$-4.1M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$-2.8M
Current Margin-23.5%
Pro Forma Margin-16.1%
WC Released (1x)$670K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.3M$-14.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.3M$-17.7M0.00x-100.0%
Bull Case9.0x11.0x$-5.7M$-15.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.7M$-18.5M0.00x-100.0%
Bear Case11.0x10.0x$-6.9M$-18.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.9M$-22.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 76.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 31.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 37 hospitals with 6-26 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-7.6% / P50=-1.6% / P75=8.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.